Using Integrative Therapies to Improve Patient-Reported Outcomes in Breast Cancer Survivors: A Living Evidence-Based Clinical Practice Guideline

Abstract

Aim: Breast cancer imposes a serious disease and economic burden on patients. This guideline aims to develop a living evidence-based clinical practice recommendations to guide the use of integrative therapies for the improvement of patient-reported outcomes (PROs) in breast cancer survivors.

Methods: We searched systematic reviews and meta-analyses or conducted de nova systematic reviews and meta-analyses to support the recommendations. The grading of recommendations, assessment, development, and evaluation approach was used to rate the certainty of evidence and the strength of recommendations.

Results: The guideline panel issued 17 recommendations: for alleviating anxiety, strong recommendations in favor of muscle relaxation training, yoga, acceptance and commitment therapy, cognitive behavioral therapy, psychological education, and Tai Chi in general breast cancer survivors; for alleviating depression, strong recommendations in favor of mindfulness therapy, cognitive behavioral therapy, group psychotherapy, muscle relaxation training, acceptanceand commitment therapy in general breast cancer survivors, and exercise intervention for patients received radiotherapy; for sleep quality, conditional recommendations for all therapies; for pain, strong recommendations in favor of exercise intervention for postoperative breast cancer survivors; for alleviating fatigue, strong recommendations in favor of mindfulness therapy and group psychotherapy in general breast cancer survivors; for improving the quality of life, strong recommendations in favor of mindfulness therapy in general breast cancer survivors, Baduanjin and exercise intervention for patients undergoing anticancer treatment.

Conclusion: This proposed guideline provides recommendations for improving the PROs of breast cancer survivors. We hope these recommendations can help support practicing physicians and other healthcare providers for breast cancer survivors.

Keywords

breast cancer survivors / clinical practice guideline / integrative therapies / patient-reported outcomes

References

[1] H. Sung, J. Ferlay, R. L. Siegel, et al., “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 71, no. 3 (2021): 209-249.

[2] M. J. Thun, M. S. Linet, J. R. Cerhan, C. A. Haiman, and D. Schottenfeld, Cancer Epidemiology and Prevention (Oxford University Press, 2017).

[3] S. Lei, R. Zheng, S. Zhang, et al., “Global Patterns of Breast Cancer Incidence and Mortality: A Population-Based Cancer Registry Data Analysis From 2000 to 2020,” Cancer Communications 41, no. 11 (2021): 1183-1194.

[4] G. H. Lyman, H. Greenlee, K. Bohlke, et al., “Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline,” Journal of Clinical Oncology 36, no. 25 (2018): 2647-2655.

[5] CAM Definitions | About CAM | Health Information | OCCAM, https://cam.cancer.gov/health_information/cam_definitions.htm.

[6] NCCIH. Complementary, Alternative, or Integrative Health: What's In a Name?, https://www.nccih.nih.gov/health/complementary-alternative-or-integrative-health-whats-in-a-name.

[7] J. J. Mao, N. Ismaila, T. Bao, et al., “Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline,” Journal of Clinical Oncology 40, no. 34 (2022): 3998-4024.

[8] H. Greenlee, M. J. Dupont-Reyes, L. G. Balneaves, et al., “Clinical Practice Guidelines on the Evidence-Based Use of Integrative Therapies During and After Breast Cancer Treatment,” CA Cancer Journal for Clinicians 67, no. 3 (2017): 194-232.

[9] E. J. Cathcart-Rake, A. J. Tevaarwerk, T. C. Haddad, S. D. D'andre, and K. J. Ruddy, “Advances in the Care of Breast Cancer Survivors,” Bmj 382 (2023): e071565.

[10] Chinese Association of Integrated Traditional and Western Medicine, Chinese Association of Traditional Chinese Medicine, Chinese Medical Association, “Diagnosis and Treatment Guide of Integrated Chinese and Western Medicine for Breast Cancer,” Beijing Traditional Chinese Medicine 43, no. 1 (2024): 7-16.

[11] J. Greenhalgh, S. Dalkin, K. Gooding, et al., Functionality and Feedback: A Realist Synthesis of the Collation, Interpretation and Utilisation of Patient-Reported Outcome Measures Data to Improve Patient Care (NIHR Journals Library, 2017).

[12] I. Ramsey, N. Corsini, A. D. Hutchinson, J. Marker, and M. Eckert, “A Core Set of Patient-Reported Outcomes for Population-Based Cancer Survivorship Research: A Consensus Study,” Journal of Cancer Survivorship 15, no. 2 (2021): 201-212.

[13] Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust (National Academies Press (US), 2011).

[14] World Health Organization. WHO Handbook for Guideline Development. 2nd ed2014.

[15] Y. Chen, K. Yang, A. Marušić, et al., “A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement,” Annals of Internal Medicine 166, no. 2 (2017): 128-132.

[16] M. C. Brouwers, M. E. Kho, G. P. Browman, et al., “AGREE II: Advancing Guideline Development, Reporting and Evaluation in Health Care,” Journal of Clinical Epidemiology 63, no. 12 (2010): 1308-1311.

[17] H. J. Schünemann, R. Mustafa, J. Brozek, et al., “GRADE Guidelines: 16. GRADE Evidence to Decision Frameworks for Tests in Clinical Practice and Public Health,” Journal of Clinical Epidemiology 76 (2016): 89-98.

[18] K. Thorlund, S. D. Walter, B. C. Johnston, T. A. Furukawa, and G. H. Guyatt, “Pooling Health-related Quality of Life Outcomes in Meta-analysis—A Tutorial and Review of Methods for Enhancing Interpretability,” Research Synthesis Methods 2, no. 3 (2011): 188-203.

[19] G. H. Guyatt, A. D. Oxman, G. E. Vist, et al., “GRADE: An Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations,” Bmj 336, no. 7650 (2008): 924-926.

[20] GRADE Handbook, https://training.cochrane.org/resource/grade-handbook.

[21] Y. Wang, T. Devji, A. Carrasco-Labra, et al., “A Step-by-Step Approach for Selecting an Optimal Minimal Important Difference,” Bmj 381 (2023): e073822.

[22] B. J. Shea, B. C. Reeves, G. Wells, et al., “AMSTAR 2: A Critical Appraisal Tool for Systematic Reviews That Include Randomised or Non-Randomised Studies of Healthcare Interventions, or Both,” Bmj 358 (2017): j4008.

[23] R. W. M. Vernooij, P. Alonso-Coello, M. Brouwers, and L. Martínez García, “Reporting Items for Updated Clinical Guidelines: Checklist for the Reporting of Updated Guidelines (CheckUp),” PLoS Medicine 14, no. 1 (2017): e1002207.

[24] J. Fang, C. Yu, J. Liu, et al., “A Systematic Review and Meta-Analysis of the Effects of Muscle Relaxation Training vs. Conventional Nursing on the Depression, Anxiety and Life Quality of Patients With Breast Cancer,” Translational Cancer Research 11, no. 3 (2022): 548-558.

[25] E.-J. Hsueh, E. W. Loh, J. J. A. Lin, and K.-W. Tam, “Effects of Yoga on Improving Quality of Life in Patients With Breast Cancer: A Meta-Analysis of Randomized Controlled Trials,” Breast Cancer (Tokyo, Japan) 28, no. 2 (2021): 264-276.

[26] L.-J. Yi, X. Tian, Y.-F. Jin, M.-J. Luo, and M. F. Jiménez-Herrera, “Effects of Yoga on Health-Related Quality, Physical Health and Psychological Health in Women With Breast Cancer Receiving Chemotherapy: A Systematic Review and Meta-Analysis,” Annals of Palliative Medicine 10, no. 2 (2021): 1961-1975.

[27] Q. Sun, H. Ye, and L. Yang, “Meta-Analysis of the Intervention Effect of Acceptance and Commitment Therapy on Breast Cancer Patients,” Chinese Journal of Nursing 57, no. 9 (2022): 1070-1079.

[28] P. Cheng, L. Xu, J. Zhang, W. Liu, and J. Zhu, “Role of Arts Therapy in Patients With Breast and Gynecological Cancers: A Systematic Review and Meta-Analysis,” Journal of Palliative Medicine 24, no. 3 (2021): 443-452.

[29] M. A. Getu, C. Chen, W. Panpan, J. F. Mboineki, K. Dhakal, and R. Du, “The Effect of Cognitive Behavioral Therapy on the Quality of Life of Breast Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,” Quality of Life Research 30, no. 2 (2021): 367-384.

[30] X.-C. Luo, J. Liu, J. Fu, et al., “Effect of Tai Chi Chuan in Breast Cancer Patients: A Systematic Review and Meta-Analysis,” Frontiers in Oncology 10 (2020): 607.

[31] F.-Y. Zhao, M. Wang, J.-E. Liu, and Y.-H. Sun, “Meta-Analysis of the Impact of Spousal Cognitive Intervention on Psychological Status and Quality of Life of Breast Cancer Patients,” Chinese Nursing Management 21, no. 9 (2021): 1351-1357.

[32] H. Setyowibowo, W. Yudiana, J. A. M. Hunfeld, et al., “Psychoeducation for Breast Cancer: A Systematic Review and Meta-Analysis,” Breast (Edinburgh, Scotland) 62 (2022): 36-51.

[33] H. Zhang, H. Xu, Z. X. Zhang, and Q. Zhang, “Efficacy of Virtual Reality-based Interventions for Patients With Breast Cancer Symptom and Rehabilitation Management: A Systematic Review and Meta-Analysis,” BMJ Open 12, no. 3 (2022): e051808.

[34] X.-X. Ye, Z.-Y. Ren, S. Vafaei, et al., “Effectiveness of Baduanjin Exercise on Quality of Life and Psychological Health in Postoperative Patients With Breast Cancer: A Systematic Review and Meta-Analysis,” Integrative Cancer Therapies 21 (2022): 15347354221104092.

[35] Y. Li, X. Li, L. Hou, L. Cao, G. Liu, and K. Yang, “Effectiveness of Dignity Therapy for Patients With Advanced Cancer: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials,” Depression and Anxiety 37, no. 3 (2020): 234-246.

[36] Y. C. Chang, T. L. Yeh, Y. M. Chang, and W. Y. Hu, “Short-Term Effects of Randomized Mindfulness-Based Intervention in Female Breast Cancer Survivors: A Systematic Review and Meta-Analysis,” Cancer Nursing 44, no. 6 (2021): E703-E714.

[37] X.-L. Zhou, L. Guang, C.-R. Chen, et al., “Meta-Analysis of the Effect of Group Psychotherapy on Intervention of Breast Cancer Patients,” Modern Preventive Medicine 47, no. 10 (2020): 1914-1920.

[38] Z. M. Xie, L. Luo, Z. Yang, and F. X. Long, “Tang DX. Meta-Analysis of Modified Xiaoyao San Combined With Chemotherapy in the Treatment of Breast Cancer,” Lishizhen Medicine and Materia Medica Research 32, no. 7 (2021): 1779-1785.

[39] Q. Shen and H. Yang, “Impact of Post-radiotherapy Exercise on Women With Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,” Journal of Rehabilitation Medicine 52, no. 10 (2020): jrm00112.

[40] H. Cheng, L. Lin, S. Wang, et al., “Aromatherapy With Single Essential Oils Can Significantly Improve the Sleep Quality of Cancer Patients: A Meta-analysis,” BMC Complementary Medicine and Therapies 22, no. 1 (2022): 187.

[41] Y. Zhang, Y. Sun, D. Li, et al., “Acupuncture for Breast Cancer: A Systematic Review and Meta-Analysis of Patient-Reported Outcomes,” Frontiers in Oncology 11 (2021): 646315.

[42] P. Xiao, S. Ding, Y. Duan, et al., “Effect of Light Therapy on Cancer-Related Fatigue: A Systematic Review and Meta-Analysis,” Journal of Pain and Symptom Management 63, no. 2 (2022): e188-e202.

[43] P. Kannan, H. Y. Lam, T. K. Ma, C. N. Lo, T. Y. Mui, and W. Y. Tang, “Efficacy of Physical Therapy Interventions on Quality of Life and Upper Quadrant Pain Severity in Women With Post-mastectomy Pain Syndrome: A Systematic Review and Meta-Analysis,” Quality of Life Research 31, no. 4 (2022): 951-973.

[44] Q. Tian, M. Xu, L. Yu, S. Yang, and W. Zhang, “The Efficacy of Virtual Reality-Based Interventions in Breast Cancer-Related Symptom Management: A Systematic Review and Meta-Analysis,” Cancer Nursing 46, no. 5 (2023): E276-E287.

[45] Q.-L. Qi, X. Han, and C Tang, “Effects of Acupuncture on Breast Cancer Patients Taking Aromatase Inhibitors,” BioMed Research International 2022 (2022): 1164355.

[46] L.-Y. Lin, L.-H. Lin, G.-L. Tzeng, et al., “Effects of Mindfulness-Based Therapy for Cancer Patients: A Systematic Review and Meta-Analysis,” Journal of Clinical Psychology in Medical Settings 29, no. 2 (2022): 432-445.

[47] G. Reverte-Pagola, H. Sánchez-Trigo, J. Saxton, and B. Sañudo, “Supervised and Non-Supervised Exercise Programs for the Management of Cancer-Related Fatigue in Women With Breast Cancer: A Systematic Review and Meta-Analysis,” Cancers 14, no. 14 (2022): 3428.

[48] Y. Yuan, L. Lin, N. Zhang, et al., “Effects of Home-Based Walking on Cancer-Related Fatigue in Patients With Breast Cancer: A Meta-Analysis of Randomized Controlled Trials,” Archives of Physical Medicine and Rehabilitation 103, no. 2 (2022): 342-352.

[49] X. Gong, G. Rong, Z. Wang, A. Zhang, X. Li, and L. Wang, “Baduanjin Exercise for Patients With Breast Cancer: A Systematic Review and Meta-Analysis,” Complementary Therapies in Medicine 71 (2022): 102886.

[50] H. H. Andersen, A. Vinther, C. M. Lund, et al., “Effectiveness of Different Types, Delivery Modes and Extensiveness of Exercise in Patients With Breast Cancer Receiving Systemic Treatment—A Systematic Review and Meta-Analysis,” Critical Reviews in Oncology/Hematology 178 (2022): 103802.

[51] NCCIH. Relaxation Techniques for Health, https://www.nccih.nih.gov/health/relaxation-techniques-what-you-need-to-know.

[52] FDA. Product Classification, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classification.cfm.

[53] T. J. Kaptchuk, “Acupuncture: Theory, Efficacy, and Practice,” Annals of Internal Medicine 136, no. 5 (2002): 374-383.

[54] H. Boon, M. Stewart, M. A. Kennard, et al., “Use of Complementary/Alternative Medicine by Breast Cancer Survivors in Ontario: Prevalence and Perceptions,” Journal of Clinical Oncology 18, no. 13 (2000): 2515-2521.

[55] C. Buettner, C. H. Kroenke, R. S. Phillips, R. B. Davis, D. M. Eisenberg, and M. D. Holmes, “Correlates of Use of Different Types of Complementary and Alternative Medicine by Breast Cancer Survivors in the Nurses' Health Study,” Breast Cancer Research and Treatment 100, no. 2 (2006): 219-227.

[56] F. Hammersen, T. Pursche, D. Fischer, A. Katalinic, and A. Waldmann, “Use of Complementary and Alternative Medicine Among Young Patients With Breast Cancer,” Breast Care 15, no. 2 (2020): 163-170.

[57] D. Hann, F. Baker, M. Denniston, and N. Entrekin, “Long-term Breast Cancer Survivors' use of Complementary Therapies: Perceived Impact on Recovery and Prevention of Recurrence,” Integrative Cancer Therapies 4, no. 1 (2005): 14-20.

[58] H. Boon, J. B. Brown, A. Gavin, M. A. Kennard, and M. Stewart, “Breast Cancer Survivors' perceptions of Complementary/Alternative Medicine (CAM): Making the Decision to Use or Not to Use,” Qualitative Health Research 9, no. 5 (1999): 639-653.

[59] A. J. Templeton, B. Thürlimann, M. Baumann, et al., “Cross-Sectional Study of Self-Reported Physical Activity, Eating Habits and Use of Complementary Medicine in Breast Cancer Survivors,” BMC Cancer 13 (2013): 153.

[60] A. K. Matthews, S. A. Sellergren, D. Huo, M. List, and G. Fleming, “Complementary and Alternative Medicine Use Among Breast Cancer Survivors,” Journal of Alternative and Complementary Medicine 13, no. 5 (2007): 555-562.

[61] J. Huebner, F. J. Prott, R. Muecke, et al., “Economic Evaluation of Complementary and Alternative Medicine in Oncology: Is There a Difference Compared to Conventional Medicine?,” Medical Principles and Practice 26, no. 1 (2017): 41-49.

[62] G. M. John, D. L. Hershman, L. Falci, Z. Shi, W.-Y. Tsai, and H. Greenlee, “Complementary and Alternative Medicine Use Among US Cancer Survivors,” Journal of Cancer Survivorship 10, no. 5 (2016): 850-864.

[63] R. R. Reich, C. A. Lengacher, C. B. Alinat, et al., “Mindfulness-Based Stress Reduction in Post-Treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom Clusters,” Journal of Pain and Symptom Management 53, no. 1 (2017): 85-95.

[64] R. Tillery and M. E McGrady, “Do Complementary and Integrative Medicine Therapies Reduce Healthcare Utilization Among Oncology Patients? A Systematic Review of the Literature and Recommendations,” European Journal of Oncology Nursing 36 (2018): 1-8.

[65] R. Behzadmehr, N. Dastyar, M. P. Moghadam, M. Abavisani, and M. Moradi, “Effect of Complementary and Alternative Medicine Interventions on Cancer Related Pain Among Breast Cancer Patients: A Systematic Review,” Complementary Therapies in Medicine 49 (2020): 102318.

[66] R. L. Nahin, P. M. Barnes, and B. J. Stussman, “Insurance Coverage for Complementary Health Approaches among Adult Users: United States, 2002 and 2012,” NCHS Data Brief no. 235 (2016): 1-8.

[67] A. M. Henneghan and T. Harrison, “Complementary and Alternative Medicine Therapies as Symptom Management Strategies for the Late Effects of Breast Cancer Treatment,” Journal of Holistic Nursing 33, no. 1 (2015): 84-97.

[68] World Acupuncture Policy and Legislation Overview Search Platform, http://rx.yunlib.cn:800/Opac/Index/bookview?book_id=1315550.

[69] NCCIH. Acupuncture: In Depth, https://www.nccih.nih.gov/.

[70] E. L. Fjær, E. R. Landet, C. L. McNamara, and T. A. Eikemo, “The Use of Complementary and Alternative Medicine (CAM) in Europe,” BMC Complementary Medicine and Therapies 20, no. 1 (2020): 108.

[71] L. E. Carlson, N. Ismaila, E. L. Addington, et al., “Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults With Cancer: Society for Integrative Oncology-ASCO Guideline,” Journal of Clinical Oncology 41, no. 28 (2023): 4562-4591.

RIGHTS & PERMISSIONS

2025 The Author(s). Journal of Evidence-Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.